Clinical Trials
4 trialsNCT02166658 2018-01-23
CaBaMet
AIO-Studien-gGmbH
Phase 2 Terminated
NCT01740570 2018-01-19
Phase I/II Cabazitaxel for Recurrent Malignant Glioma
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT01866449 2017-10-26
Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
University of Ulm
Phase 2 Completed
NCT01913067 2014-07-24
CRANIAL
Jules Bordet Institute
Phase 2 Withdrawn